Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy

Human Molecular Genetics

Volumn 18, Issue 14, 2009, Pages 2584-2598

  Li, Hong ^a   Mittal, Ashwani ^a   Makonchuk, Denys Y ^a   Bhatnagar, Shephali ^a   Kumar, Ashok ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(4 BIPHENYLYLSULFONYL) AMINO] 3 PHENYLPROPIONIC ACID; BETA DYSTROGLYCAN; CAVEOLIN 3; GELATINASE B; I KAPPA B; MATRIX METALLOPROTEINASE INHIBITOR; NEURONAL NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION REGULATION; GENE TARGETING; IN VIVO STUDY; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; MUSCLE CELL; MUSCLE NECROSIS; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

MUS;

EID: 67649851014     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp191     Document Type: Article

References (61)

1. Emery, A.E. (2002) The muscular dystrophies. Lancet, 359, 687-695.
2. Cohn, R.D. and Campbell, K.P. (2000) Molecular basis of muscular dystrophies. Muscle Nerve, 23, 1456-1471.
3. Allamand, V. and Campbell, K.P. (2000) Animal models for muscular dystrophy: Valuable tools for the development of therapies. Hum. Mol. Genet., 9, 2459-2467.
4. Dalkilic, I. and Kunkel, L.M. (2003) Muscular dystrophies: Genes to pathogenesis. Curr. Opin. Genet. Dev., 13, 231-238.
5. Rando, T.A. (2001) The dystrophin - glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve, 24, 1575-1594.
6. Kumar, A. and Boriek, A.M. (2003) Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: A possible role in Duchenne muscular dystrophy. FASEB J., 17, 386-396.
7. Kumar, A., Khandelwal, N., Malya, R., Reid, M.B. and Boriek, A.M. (2004) Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J., 18, 102-113.
8. Judge, L.M., Haraguchiln, M. and Chamberlain, J.S. (2006) Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J. Cell. Sci., 119, 1537-1546.
9. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
10. Engvall, E. and Wewer, U.M. (2003) The new frontier in muscular dystrophy research: Booster genes. FASEB J., 17, 1579-1584.
11. Mott, J.D. and Werb, Z. (2004) Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol., 16, 558-564.
12. Vu, T.H. and Werb, Z. (2000) Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev., 14, 2123-2133.
13. Page-McCaw, A., Ewald, A.J. and Werb, Z. (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol., 8, 221-233.
14. Chandler, S., Miller, K.M., Clements, J.M., Lury, J., Corkill, D., Anthony, D.C., Adams, S.E. and Gearing, A.J. (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J. Neuroimmunol., 72, 155-161.
15. Hu, J., Van den Steen, P.E., Sang, Q.X. and Opdenakker, G. (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov., 6, 480-498.
16. Waubant, E., Goodkin, D.E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.B., Stabler, G. and Miller, K. (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology, 53, 1397-1401.
17. Hoyhtya, M., Hujanen, E., Turpeenniemi-Hujanen, T., Thorgeirsson, U., Liotta, L.A. and Tryggvason, K. (1990) Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. Int. J. Cancer, 46, 282-286.
18. Turpeenniemi-Hujanen, T., Thorgeirsson, U.P., Hart, I.R., Grant, S.S. and Liotta, L.A. (1985) Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Natl Cancer Inst., 75, 99-103.
19. Carmeli, E., Moas, M., Reznick, A.Z. and Coleman, R. (2004) Matrix metalloproteinases and skeletal muscle: A brief review. Muscle Nerve 29, 191-197.
20. Choi, Y.C. and Dalakas, M.C. (2000) Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology, 54, 65-71.
21. Koskinen, S.O., Kjaer, M., Mohr, T., Sorensen, F.B., Suuronen, T. and Takala, T.E. (2000) Type IV collagen and its degradation in paralyzed human muscle: Effect of functional electrical stimulation. Muscle Nerve, 23, 580-589.
22. Schiotz Thorud, H.M., Stranda, A., Birkeland, J.A., Lunde, P.K., Sjaastad, I., Kolset, S.O., Sejersted, O.M. and Iversen, P.O. (2005) Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol., 289, R389-R394.
23. Davies, J.E., Wang, L., Garcia-Oroz, L., Cook, L.J., Vacher, C., O'Donovan, D.G. and Rubinsztein, D.C. (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat. Med., 11, 672-677.
24. Hnia, K., Hugon, G., Rivier, F., Masmoudi, A., Mercier, J. and Mornet, D. (2007) Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. Am. J. Pathol., 170, 633-643.
25. Kherif, S., Lafuma, C., Dehaupas, M., Lachkar, S., Fournier, J.G., Verdiere-Sahuque, M., Fardeau, M. and Alameddine, H.S. (1999) Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: A study in experimentally injured and mdx muscles. Dev. Biol., 205, 158-170.
26. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
27. Acharyya, S., Villalta, S.A., Bakkar, N., Bupha-Intr, T., Janssen, P.M., Carathers, M., Li, Z.W., Beg, A.A., Ghosh, S., Sahenk, Z. et al. (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest., 117, 889-901.
28. Chakraborti, S., Mandal, M., Das, S., Mandal, A. and Chakraborti, T. (2003) Regulation of matrix metalloproteinases: An overview. Mol. Cell. Biochem., 253, 269-285.
29. Li, H., Mittal, A., Paul, P.K., Kumar, M., Srivastava, D.S., Tyagi, S.C. and Kumar, A. (2008) Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase-9 production (MMP-9) in skeletal muscle through the activation of nuclear factor-kappa B-inducing kinase and p38 mitogen-activated protein kinase: A potential role of MMP-9 in myopathy. J. Biol. Chem., 284, 4439-4450.
30. Srivastava, A.K., Qin, X., Wedhas, N., Arnush, M., Linkhart, T.A., Chadwick, R.B. and Kumar, A. (2007) Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J. Biol. Chem., 282, 35113-35124.
31. May, M.J., D'Acquisto, F., Madge, L.A., Glockner, J., Pober, J.S. and Ghosh, S. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science, 289, 1550-1554.
32. Straub, V. and Campbell, K.P. (1997) Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol., 10, 168-175.
33. Kjaer, M. (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol. Rev., 84 649-698.
34. Wehling-Henricks, M., Sokolow, S., Lee, J.J., Myung, K.H., Villalta, S.A. and Tidball, J.G. (2008) Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum. Mol. Genet., 17, 2280-2292.
35. Massague, J. (2008) TGFbeta in Cancer. Cell, 134, 215-230.
36. Andreetta, F., Bernasconi, P., Baggi, F., Ferro, P., Oliva, L., Arnoldi, E., Cornelio, F., Mantegazza, R. and Confalonieri, P. (2006) Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy. J. Neuroimmunol., 175 77-86.
37. Gosselin, L.E., Williams, J.E., Personius, K. and Farkas, G.A. (2007) A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: Impact of pirfenidone. Muscle Nerve, 35, 208-216.
38. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Cornelio, F., Morandi, L. and Mantegazza, R. (1995) Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest., 96, 1137-1144.
39. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev., 14, 163-176.
40. Ohlendieck, K. and Campbell, K.P. (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell. Biol. 115, 1685-1694.
41. Michaluk, P., Kolodziej, L., Mioduszewska, B., Wilczynski, G.M., Dzwonek, J., Jaworski, J., Gorecki, D.C., Ottersen, O.P. and Kaczmarek, L. (2007) Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J. Biol. Chem., 282, 16036-16041.
42. Zhong, D., Saito, F., Saito, Y., Nakamura, A., Shimizu, T. and Matsumura, K. (2006) Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Biochem. Biophys. Res. Commun., 345, 867-871.
43. Le Grand, F. and Rudnicki, M.A. (2007) Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol., 19, 628-633.
44. Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., Tsuzuki, H., Maekawa, R., Yoshioka, T., Kawada, K. et al. (1998) Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J. Med. Chem., 41, 640-649.
45. Yamaguchi, M., Jadhav, V., Obenaus, A., Colohan, A. and Zhang, J.H. (2007) Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury. Neurosurgery, 61, 1067-1075.
46. Khurana, T.S. and Davies, K.E. (2003) Pharmacological strategies for muscular dystrophy. Nat. Rev. Drug. Discov., 2, 379-390.
47. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
48. Morrison, J., Lu, Q.L., Pastoret, C., Partridge, T. and Bou-Gharios, G. (2000) T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab. Invest., 80, 881-891.
49. Morrison, J., Palmer, D.B., Cobbold, S., Partridge, T. and Bou-Gharios, G. (2005) Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. Am. J. Pathol., 166, 1701-1710.
50. Spencer, M.J., Montecino-Rodriguez, E., Dorshkind, K. and Tidball, J.G. (2001) Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin. Immunol., 98 235-243.
51. Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L.E., Schoen, F.J., Kelly, R.A., Werb, Z., Libby, P. et al. (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest., 106, 55-62.
52. Lim, D.H., Cho, J.Y., Miller, M., McElwain, K., McElwain, S. and Broide, D.H. (2006) Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am. J. Physiol. Lung Cell Mol. Physiol., 291, L265-L271.
53. Garcia-Cardena, G., Martasek, P., Masters, B.S., Skidd, P.M., Couet, J., Li, S., Lisanti, M.P. and Sessa, W.C. (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem., 272, 25437-25440.
54. Galbiati, F., Volonte, D., Chu, J.B., Li, M., Fine, S.W., Fu, M., Bermudez, J., Pedemonte, M., Weidenheim, K.M., Pestell, R.G. et al. (2000) Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl Acad. Sci. USA, 97, 9689-9694.
55. Vaghy, P.L., Fang, J., Wu, W. and Vaghy, L.P. (1998) Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett., 431, 125-127.
56. Heslop, L., Morgan, J.E. and Partridge, T.A. (2000) Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell. Sci., 113, 2299-2308.
57. Irintchev, A., Zweyer, M. and Wernig, A. (1997) Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscul. Disord., 7, 117-125.
58. Duance, V.C., Stephens, H.R., Dunn, M., Bailey, A.J. and Dubowitz, V. (1980) A role for collagen in the pathogenesis of muscular dystrophy? Nature, 284, 470-472.
59. Sanes, J.R. (2003) The basement membrane/basal lamina of skeletal muscle. J. Biol. Chem., 278, 12601-12604.
60. Chen, Y.W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R. and Hoffman, E.P. (2005) Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology, 65, 826-834.
61. Amalfitano, A. and Chamberlain, J.S. (1996) The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve, 19, 1549-1553.